(19 days)
No
The summary describes standard physiological monitoring and signal transmission, with no mention of AI, ML, or related concepts in the intended use, device description, or performance studies.
No.
The device is described as providing continuous monitoring of electrocardiographic and pulse blood oxygen saturation signals to detect abnormal cardiac rhythms and desaturation. It is a diagnostic and monitoring device, not one that provides therapy or treatment.
Yes
The device detects "abnormal cardiac rhythms" and "desaturation caused by abnormal pulmonary/circulatory functions," which indicates it is used to identify medical conditions—a characteristic of a diagnostic device.
No
The device description explicitly states it is a "portable, battery-powered, patient-worn transmitter" and describes hardware components like electrodes, remote sensors, and a display. This indicates it is a physical device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for the continuous monitoring of electrocardiographic signals and pulse blood oxygen saturation signals in patients. This involves monitoring physiological parameters directly from the patient's body.
- Device Description: The device description confirms it's a patient-worn transmitter that monitors ECG and SpO2 data.
- Lack of In Vitro Activity: An IVD is a medical device that is used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to provide information about a person's health. This device does not perform any tests on samples taken from the body. It directly measures signals from the patient.
Therefore, the Spacelabs Healthcare AriaTele Telemetry Transmitter is a patient monitoring device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Spacelabs Healthcare AriaTele Telemetry Transmitter (96281), when used in conjunction with a Spacelabs Healthcare Ultraview patient monitor and telemetry receiver, provides a means for the continuous monitoring of electrocardiographic signals in order to detect abnormal cardiac rhythms, including life-threatening events such as high and low heart rates, asystole, and ventricular fibrillation. Optionally, on adult patients, additional abnormal cardiac rhythms, such as ventricular runs, tachycardia, and ST segment deviations are detected.
The 96281 also provides a means for both continuous and episodic monitoring of pulse blood oxygen saturation signals in order to detect desaturation caused by abnormal pulmonary/ circulatory functions.
The 96281 is intended for use with either adult or neonatal patient populations in a hospital environment.
Product codes
MXH, DPS, DQA
Device Description
The Ultraview™ Digital Telemetry System (AriaTele) are portable, battery-powered, patient-worn transmitters that monitor electrocardiography (ECG) activity and oxygen saturation (SpO2) data (96281-C only), and transmit this information to a telemetry receiver module.
There are three (3) variants of the AriaTele:
- Model 96281-A: ECG; .
- Model 96281-B: ECG with display; and .
- . Model 96281-C: ECG and SpO2 with display.
The AriaTele is compatible with the Ultraview SL 3800-38/-39 central monitor, and the Ultraview and Ultraview SL line of bedside monitors, collectively called "monitors." The AriaTele is also compatible with the 90478 Digital Telemetry System Receiver and Receiver Housing (90479-A, 90479-B). The receiver housing is related to the central monitor. The receiver module can go in the housing or in a bedside monitor.
The AriaTele functions as part of a digital telemetry system. The digital telemetry system consists of transmitters, diversity antennas, receiver modules, and either a receiver housing or a monitor. Typically, a request comes from a monitor to obtain data from electrodes and/or remote sensors attached to a patient which are connected to the transmitter. The monitor tells a receiver what channel to begin listening on-one that matches the transmitter on the patient.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult or neonatal patients
Intended User / Care Setting
Hospital environment.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Electrical Safety
The AriaTele was tested for performance in accordance with the following Standards:
- IEC 60601-1: 2005, Medical electrical equipment Part 1. General . requirements for basic safety and essential performance;
- IEC 60529: 1989, Am1: 1999, Degree of protection provided by . enclosures; and
- UL 60601-1: 2003, Medical electrical equipment Part 1. General . requirements for safety.
Test results indicated that the AriaTele complies with the Standards.
Electromagnetic Compatibility (EMC) Testing
The AriaTele was tested for performance in accordance with the following Standard:
- IEC 60601-1-2: 2007, Medical electrical equipment – Part 1-2: General requirements for basic safety and essential performance – Collateral standard: Electromagnetic compatibility – Requirements and tests.
Test results indicated that the AriaTele complies with the Standards.
Software Testing
Software device modifications made to the AriaTele were designed and developed according to a robust software development process, and were rigorously verified and validated.
Software information is provided in accordance with internal documentation and the following Standards and guidance documents:
- FDA guidance: The content of premarket submissions for software contained in medical devices, 11 May 05;
- FDA guidance: Off-the-shelf software use in medical devices, 09 Sep 99; and
- FDA guidance: General principles of software validation; Final guidance for industry and FDA staff, 11 Jan 02;
Test results indicate that the AriaTele complies with its predetermined specification and the Standards and guidance documents.
Performance Testing
The AriaTele was tested for performance in accordance with internal documentation and the following Standards:
- IEC 60601-2-27: 2011, Medical electrical equipment - Part 2-27: Particular requirements for the basic safety and essential performance of electrocardiographic monitoring equipment;
- IEC 60601-2-49: 2011, Medical electrical equipment - Part 2-49: Particular requirements for the safety of multifunction patient monitoring equipment ;
- IEC 80601-2-61: 2011, Medical electrical equipment -- Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment; and
- IEC 62366: 2007; Medical devices - Application of usability engineering to medical devices.
Test results indicated that the AriaTele complies with its predetermined specification and with the applicable Standards.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
510(k) Summary
JUN - 6 2012
| Submission Date: | 15 May 2012 | |
|---|---|---|
| Submitter: | Spacelabs Healthcare | |
| 5150 220th Avenue SE | ||
| Issaquah, WA 98029 | ||
| Submitter Contact: | Spacelabs Healthcare | |
| 5150 220th Avenue SE | ||
| Issaquah, WA 98029 | ||
| Mr. David J. Geraghty | ||
| Spacelabs Healthcare | ||
| Phone: +1 (425) 657-7200, ext 5889 | ||
| Fax: +1 (425) 657-7210 | ||
| Email: david.geraghty@spacelabs.com | ||
| Official Contact: | Thomas Kroenke | |
| Principal Consultant | ||
| Speed To Market, Inc. | ||
| PO Box 3018 | ||
| Nederland, CO 80466 USA | ||
| tkroenke@speedtomarket.net | ||
| 303 956 4232 | ||
| Manufacturing Site: | Spacelabs Healthcare | |
| 5150 220th Avenue SE | ||
| Issaquah, WA 98029 | ||
| Trade Name: | Spacelabs Healthcare AriaTele Telemetry Transmitter (96281) | |
| Common and | ||
| Classification Name: | Monitor, Physiological, Patient (With Arrhythmia Detection or | |
| Alarms); Electrocardiograph; Oximeter | ||
| Classification | ||
| Regulation: | 21 CFR §870.1025; 21 CFR §870.2340; 21 CFR §870.2700 | |
| Product Code: | MXH; DPS; DQA | |
| Substantially | ||
| Equivalent Devices: | New Spacelabs Model | |
| Spacelabs Healthcare | ||
| AriaTele Telemetry | ||
| Transmitter (96281) K983996 Spacelabs Medical, Inc | ||
| Spacelabs Medical | ||
| Ultraview™ Digital |
Telemetry System
:
1
Device Description:
The Ultraview™ Digital Telemetry System (AriaTele) are portable, battery-powered, patient-worn transmitters that monitor electrocardiography (ECG) activity and oxygen saturation (SpO2) data (96281-C only), and transmit this information to a telemetry receiver module.
There are three (3) variants of the AriaTele:
- Model 96281-A: ECG; .
- Model 96281-B: ECG with display; and .
- . Model 96281-C: ECG and SpO2 with display.
The AriaTele is compatible with the Ultraview SL 3800-38/-39 central monitor, and the Ultraview and Ultraview SL line of bedside monitors, collectively called "monitors." The AriaTele is also compatible with the 90478 Digital Telemetry System Receiver and Receiver Housing (90479-A, 90479-B). The receiver housing is related to the central monitor. The receiver module can go in the housing or in a bedside monitor.
The AriaTele functions as part of a digital telemetry system. The digital telemetry system consists of transmitters, diversity antennas, receiver modules, and either a receiver housing or a monitor. Typically, a request comes from a monitor to obtain data from electrodes and/or remote sensors attached to a patient which are connected to the transmitter. The monitor tells a receiver what channel to begin listening on-one that matches the transmitter on the patient.
Intended Use:
The Spacelabs Healthcare AriaTele Telemetry Transmitter (96281), when used in conjunction with a Spacelabs Healthcare Ultraview patient monitor and telemetry receiver, provides a means for the continuous monitoring of electrocardiographic signals in order to detect abnormal cardiac rhythms, including life-threatening events such as high and low heart rates, asystole, and ventricular fibrillation. Optionally, on adult patients, additional abnormal cardiac rhythms, such as ventricular runs, tachycardia, and ST segment deviations are detected.
The 96281 also provides a means for both continuous and episodic monitoring of pulse blood oxygen saturation signals in order to detect desaturation caused by abnormal pulmonary/ circulatory functions.
The 96281 is intended for use with either adult or neonatal patient populations in a hospital environment.
2
Technology Comparison:
The AriaTele employs the same technological characteristics as the predicate device.
| Characteristic | Predicate Device | Proposed Device |
|---|---|---|
| Parameters | Electrocardiography (ECG); Oxygen | |
| Saturation (SpO2) and Pulse Rate (PR); | ||
| Non-invasive Blood Pressure (NIBP) | ECG; SpO2; and PR | |
| Accuracy of ECG | ||
| Signal | ||
| Reproduction | AAMI EC13 | IEC 60601-2-27 |
| SpO₂ Accuracy | Adult/Neonate: | |
| $\pm$ 3 % over 70 - 100 % | ||
| Unspecified over 0 - 69 % | Adult: | |
| $\pm$ 2 % over 70 - 100 % | ||
| Unspecified over 0 - 69 % | ||
| Neonate: | ||
| $\pm$ 3.25 % over 70 - 100 % | ||
| Unspecified over 0 - 69 % | ||
| PR Accuracy | Adult/Neonate: | |
| $\pm$ 3 bpm over full range | Same. | |
| Signal Quality | ||
| Display | No | Yes |
| Power Source | Battery | Same |
Summary of Performance Testing:
Electrical Safety
The AriaTele was tested for performance in accordance with the following Standards:
- IEC 60601-1: 2005, Medical electrical equipment Part 1. General . requirements for basic safety and essential performance;
- IEC 60529: 1989, Am1: 1999, Degree of protection provided by . enclosures; and
- UL 60601-1: 2003, Medical electrical equipment Part 1. General . requirements for safety.
Test results indicated that the AriaTele complies with the Standards.
3
510(k) Summary
| Electromagnetic
Compatibility (EMC)
Testing | The AriaTele was tested for performance in accordance with the
following Standard: | |
|---------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | IEC 60601-1-2: 2007, Medical electrical equipment – Part 1-2:
General requirements for basic safety and essential performance –
Collateral standard: Electromagnetic compatibility – Requirements
and tests. | |
| | Test results indicated that the AriaTele complies with the Standards. | |
| Software Testing | Software device modifications made to the AriaTele were designed and
developed according to a robust software development process, and
were rigorously verified and validated. | |
| | Software information is provided in accordance with internal
documentation and the following Standards and guidance documents: | |
| | • | FDA guidance: The content of premarket submissions for software
contained in medical devices, 11 May 05; |
| | • | FDA guidance: Off-the-shelf software use in medical devices, 09
Sep 99; and |
| | • | FDA guidance: General principles of software validation; Final
guidance for industry and FDA staff, 11 Jan 02; |
| | Test results indicate that the AriaTele complies with its predetermined
specification and the Standards and guidance documents. | |
| Performance Testing | The AriaTele was tested for performance in accordance with internal
documentation and the following Standards: | |
| | • | IEC 60601-2-27: 2011, Medical electrical equipment - Part 2-27:
Particular requirements for the basic safety and essential
performance of electrocardiographic monitoring equipment; |
| | • | IEC 60601-2-49: 2011, Medical electrical equipment - Part 2-49:
Particular requirements for the safety of multifunction patient
monitoring equipment ; |
| | • | IEC 80601-2-61: 2011, Medical electrical equipment -- Part 2-61:
Particular requirements for basic safety and essential performance
of pulse oximeter equipment; and |
| | • | IEC 62366: 2007; Medical devices - Application of usability
engineering to medical devices. |
| | Test results indicated that the AriaTele complies with its predetermined
specification and with the applicable Standards. | |
4
Conclusion Verification and validation activities were conducted to establish the performance and safety characteristics of the software device modifications made to the AriaTele. The results of these activities demonstrate that the AriaTele is safe and effective when used in accordance with its intended use and labeling.
Therefore, the AriaTele is considered substantially equivalent to the predicate device.
5
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring. MD 20993-0002
JUN - 6 2012
Spacelabs Healthcare c/o Mr. Thomas Kroenke Principal Consultant Speed To Market, Inc. P.O. Box 3018 Nederland, CO 80466
Re: K121480
Trade/Device Name: Spacelabs Healthcare AriaTele Telemetry Transmitter (96281) Regulatory Number: 21 CFR 870.1025 Regulation Name: Patient Physiological Monitor (with arrhythmia detection or alarms) Regulatory Class: II (two) Product Code: MHX Dated: May 15, 2012
Received: May 18, 2012
Dear Mr. Kroenke:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be
6
Page 2 - Mr. Thomas Kroenke
found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA mav publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Bram D. Zuckerman, M.D.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
K121480
Indications for Use
510(k) Number (if known): . K
Device Name:
Indications for Use:
Spacelabs Healthcare AriaTele Telemetry Transmitter (96281)
The Spacelabs Healthcare AriaTele Telemetry Transmitter (96281), when used in conjunction with a Spacelabs Healthcare Ultraview patient monitor and telemetry receiver, provides a means for the continuous monitoring of electrocardiographic signals in order to detect abnormal cardiac rhythms, including life-threatening events such as high and low heart rates, asystole, and ventricular fibrillation. Optionally, on adult patients, additional abnormal cardiac rhythms, such as ventricular runs, tachycardia, and ST segment deviations are detected.
The 96281 also provides a means for both continuous and episodic monitoring of pulse blood oxygen saturation signals in order to detect desaturation caused by abnormal pulmonary/ circulatory functions.
The 96281 is intended for use with either adult or neonatal patient populations in a hospital environment.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrences of CDRH, Office of Device Evaluation (ODE)
Bigislon Stan-Off Division of Cardiovascular Devices
510(k) Number K121480